Early loss of CREBBP confers malignant stem cell properties on lymphoid progenitors by Huntly, B, Horton, S, Giotopoulos, G, Yun, H, Vohra, S, Sheppard, O, Bashford-Rogers, R, Rashid, M, Sasca, D, Basheer, F, Gallipoli, P, Okosun, J, Hodson, D, Fitzgibbon, J, Du, M, Adams, D

The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia by Lawson, H, Holt-Martyn, JP, Dembitz, V, Kabayama, Y, Wang, LM, Bellani, A, Atwal, S, Saffoon, N, Durko, J, van de Lagemaat, LN, De Pace, AL, Tumber, A, Corner, T, Salah, E, Arndt, C, Brewitz, L, Bowen, M, Dubusse, L, George, D, Allen, L, Guitart, AV, Fung, TK, So, CWE, Schwaller, J, Gallipoli, P, O'Carroll, D, Schofield, CJ, Kranc, KR

Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors by Horton, S, Giotopoulos, G, Yun, H, Vohra, S, Sheppard, O, Bashford-Rogers, R, Rashid, M, Clipson, A, Chan, W, Sasca, D, Yiangou, L, Osaki, H, Basheer, F, Gallipoli, P, Burrows, N, Erdem, A, Sybirna, A, Foerster, S, Zhao, W, Sustic, T, Petrunkina Harrison, A, Laurenti, E, Okosun, J, Hodson, D, Wright, P, Smith, K, Maxwell, P, Fitzgibbon, J, Du, M, Adams, D, Huntly, B